Partner Apotex Corp. (Apotex) to market and distribute to the U.S. healthcare market ...
The FDA encourages health care providers to educate their patients about the risks associated with using compounded topical finasteride. Reports of adverse events associated with the use of compounded ...
Please provide your email address to receive an email when new articles are posted on . FDA warned of potential serious risks when using compounded topical finasteride. There are no FDA-approved ...
The US Food and Drug Administration (FDA) said Tuesday it has become aware of reports of adverse events associated with compounded topical finasteride products, and it has issued an alert for ...
Appili provides update on Aditxt (ADTX) transaction and encourages shareholders to vote their shares as soon as possible for the November 6, 2024 shareholders meeting HALIFAX, Nova Scotia, Oct. 31, ...
A chronic form of eczema that develops specifically in the hands now has its first approved FDA-approved drug, a topical cream from dermatological medicines specialist LEO Pharma. The Wednesday ...
A recent FDA alert warned of lasting side effects from the topical form of finasteride, a popular hair loss medication. The FDA has received 32 reports of adverse effects, including erectile ...
Morning Overview on MSN
Most anti-aging peptides fall short, but a few show promise
The anti-aging peptide market has exploded in recent years, with dozens of compounds sold as injectables, topical serums, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results